No insider purchase over the last 90 days. The latest, by Cheldin Cary, was filed 30 Aug 2021.
Every trade that managers of Unico American Corp disclose to SEC (Form 4) is tracked on this page. The company sits in the Banks sector. Nothing new has been filed by managers of Unico American Corp in twelve months, the latest record being from 21 September 2021.
The full history, which starts in 2018, counts 54 purchases against 18 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2021 · cache
25 of 72 declarations
Unico American Corp. (ticker: UNAM) is a U.S.-based insurance holding company whose historical business has centered on property and casualty insurance. SEC filings show that UNAM was listed on The Nasdaq Stock Market LLC, and later filings indicate that the company’s securities registration was revoked effective January 24, 2025. For investors, that means Unico should be viewed less as a conventional listed insurer and more as a special-situation / distressed legacy insurance story. ([sec.gov](https://www.sec.gov/Archives/edgar/data/100716/000010071620000021/form-10k.htm?utm_source=openai))
The company was incorporated in Nevada in 1969 and operated for years with principal offices in California, including Calabasas/Woodland Hills references in SEC records. Its core operating subsidiary has been Crusader Insurance Company, which underwrites commercial property and casualty insurance. Unico has also operated a set of smaller support businesses: Unifax Insurance Systems and American Insurance Brokers provided marketing and underwriting support; American Acceptance Company handled insurance premium financing; and Insurance Club, Inc. (AAQHC) provided membership association services. ([sec.gov](https://www.sec.gov/Archives/edgar/data/100716/000010071620000021/form-10k.htm?utm_source=openai))
From a competitive standpoint, Unico historically competed as a niche specialty P&C player rather than a scale insurer. Its model relied on underwriting selected commercial risks, working with specialized independent brokers and agents, and using targeted distribution rather than broad mass-market reach. That niche focus can be advantageous when underwriting discipline is strong, but it also leaves a small insurer more exposed to reserve deterioration, claims inflation, and concentration risk. SEC discussion of Crusader highlights exposure to social inflation and adverse loss development, which are recurring pressure points for small commercial P&C writers in the United States. ([sec.gov](https://www.sec.gov/Archives/edgar/data/100716/000010071620000021/form-10k.htm?utm_source=openai))
Recent developments have been dominated by regulatory and corporate actions. In 2023, public disclosures indicated that Crusader Insurance Company, Unico’s principal subsidiary, had been placed into conservation, and Unico also received notice of Nasdaq delisting. In January 2025, the SEC’s administrative proceeding stated that the revocation of registration of Unico American Corporation’s securities was effective as of January 24, 2025. Those events materially altered the investment case by reducing liquidity and making the stock a much less investable public-market name. ([finance.yahoo.com](https://finance.yahoo.com/news/unico-american-corporations-principal-subsidiary-201500093.html?utm_source=openai))
For French-speaking investors, the key takeaway is that Unico American Corp. is a United States insurance company with a long operating history, California roots, and a specialty P&C profile, but its recent history is defined by conservation, delisting risk, and the loss of normal exchange-trading status. In other words, the business description still matters, but the market structure and regulatory backdrop now dominate the equity story. ([sec.gov](https://www.sec.gov/Archives/edgar/data/100716/000010071620000021/form-10k.htm?utm_source=openai))
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2021 | 36.4 m USD | -5.7 m USD | -1.07 USD | 10-K/A |
| Dec 2020 | 32.6 m USD | -21.5 m USD | -4.05 USD | 10-K/A |
| Dec 2019 | 31.4 m USD | -3.1 m USD | -0.59 USD | 10-K |
| Dec 2018 | 33.6 m USD | -3.2 m USD | -0.60 USD | 10-K |
| Dec 2017 | 36.8 m USD | -8.7 m USD | -1.64 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.